Guardant Health (GH) Tops Q2 EPS by 21c

Guardant Health (NASDAQ: GH) reported Q2 EPS of ($1.00), $0.21 better than the analyst estimate of ($1.21). Revenue for the quarter came in at $109.1 million versus the consensus estimate of $105.08 million.

GUIDANCE:

Guardant Health sees FY2022 revenue of $460-470 million, versus the consensus of $465.3 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
• General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance